Article info

Download PDFPDF
Original research
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel

Authors

  • Wu Jiang State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Lin Li Genetron Health (Beijing) Technology, Co. Ltd, Beijing, China PubMed articlesGoogle scholar articles
  • Chuan-Feng Ke Department of General Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Wei Wang Department of Gastrointestinal Surgery, Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China PubMed articlesGoogle scholar articles
  • Bin-Yi Xiao State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ling-Heng Kong State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Jing-Hua Tang State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yuan Li State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xiao-Dan Wu State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ying Hu Genetron Health (Beijing) Technology, Co. Ltd, Beijing, China PubMed articlesGoogle scholar articles
  • Wei-Hua Guo Genetron Health (Beijing) Technology, Co. Ltd, Beijing, China PubMed articlesGoogle scholar articles
  • Si-Zhen Wang Genetron Health (Beijing) Technology, Co. Ltd, Beijing, China PubMed articlesGoogle scholar articles
  • De-Sen Wan State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Rui-Hua Xu Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zhi-Zhong Pan State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  • Pei-Rong Ding State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China PubMed articlesGoogle scholar articles
  1. Correspondence to Prof. Pei-Rong Ding, Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China; dingpr{at}sysucc.org.cn; Prof. Zhi-Zhong Pan, Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China; panzhzh{at}sysucc.org.cn
View Full Text

Citation

Jiang W, Li L, Ke C, et al
Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel

Publication history

  • Received June 2, 2020
  • Revised January 12, 2021
  • Accepted January 16, 2021
  • First published February 9, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.